MIAMI BEACH -- The surgical dogma favoring axillary dissection in breast cancer continues to give way to more selective data-driven strategies that allow more women to avoid axillary surgery, an ...

In the AXSANA/EUBREAST 3(R) study, researchers compared data about recurrence outcomes of more-invasive and less-invasive lymph node procedures.

Is axillary node dissection beneficial in patients with T1 or T2 breast cancer whose initial therapy is lumpectomy and tangential breast irradiation? The authors performed a randomized controlled ...

Dr. Rosenberg answers the question: 'When Is Sentinel Node Biopsy Considered?' — -- Question: When is a sentinel node biopsy considered, and when is an axillary lymph node dissection necessary?

Recently, omission of axillary lymph node dissection among patients with early breast cancer has been found to have no detrimental effect on outcomes in most cases, continuing a trend toward less ...

Pamela Kedziera answers: 'How Will I Feel After Lymph Node Dissection?' — -- Question: What are some possible sensations I may feel in my hand and arm after an axillary lymph node dissection, and ...

Targeted axillary dissection (TAD) is a relatively new breast cancer procedure. It allows surgical oncologists to specifically locate a lymph node that contained cancer before chemotherapy, remove it ...

A new procedure improves the accuracy of axillary staging and pathologic evaluation in clinically node-positive breast cancer, and reduces the need for a more invasive procedure with debilitating ...

Axillary lymph node dissection did not improve survival outcomes in a cohort of women with T1-T2 breast cancer who had received sentinel node dissection, according to study results. Eligible women had ...

Skipping standard axillary lymph node dissection led to very low rates of axillary recurrence in patients with node-positive breast cancer who became node-negative following neoadjuvant chemotherapy, ...

A new procedure developed by surgeons at The University of Texas MD Anderson Cancer Center improves the accuracy of axillary staging and pathologic evaluation in clinically node-positive breast cancer ...